Biovail Sues FDA Over Generic Wellbutrin
Scrambling to halt shipments of a generic copy of the antidepressant Wellbutrin XL, Canadian pharmaceutical company Biovail Corp. has renewed its fight against the U.S. Food and Drug Administration in another...To view the full article, register now.
Already a subscriber? Click here to view full article